2023
Treatment of Stiff-Person Syndrome with Botulinum Toxin
Safarpour D, Jabbari B. Treatment of Stiff-Person Syndrome with Botulinum Toxin. 2023, 174-179. DOI: 10.1017/9781009105033.021.Peer-Reviewed Original ResearchBotulinum toxinStiff-person syndromeBotulinum toxin therapyToxin therapyToxin formulationsBedside guidanceInjection siteCosmetic treatmentCadaveric dissectionAnatomical landmarksSmile correctionToxinTreatmentEyesInjectionClinician's eyeLower facePathophysiologySyndromeTherapyCliniciansPhysiciansDissectionTreatment of Plantar Fasciitis/Plantar Fasciopathy with Botulinum Neurotoxins
Safarpour D, Mittal S, Jabbari B. Treatment of Plantar Fasciitis/Plantar Fasciopathy with Botulinum Neurotoxins. 2023, 269-274. DOI: 10.1017/9781009105033.034.Peer-Reviewed Original ResearchBotulinum toxinBotulinum toxin therapyPlantar FasciopathyToxin therapyToxin formulationsBedside guidanceInjection siteCosmetic treatmentCadaveric dissectionAnatomical landmarksSmile correctionBotulinum neurotoxinToxinTreatmentEyesInjectionClinician's eyeLower facePathophysiologyTherapyCliniciansPhysiciansDissection
2022
Botulinum Toxin Treatment of Pain Disorders
Jabbari B. Botulinum Toxin Treatment of Pain Disorders. 2022 DOI: 10.1007/978-3-030-99650-5.Peer-Reviewed Original ResearchBotulinum toxin treatmentPain disordersToxin treatmentPost-traumatic neuralgiaPain medicine specialistsEvidence-based literature reviewLow back painPain syndromeAnalgesic effectPain categoriesPlantar fasciitisBack painBoNT therapyTreatment menuIllustrative case historiesMedicine specialistsAnimal studiesPainDisordersTreatmentClinical chaptersLiterature reviewFasciitisNeuralgiaInternists
2018
Botulinum toxin in essential hand tremor - A randomized double-blind placebo-controlled study with customized injection approach
Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B. Botulinum toxin in essential hand tremor - A randomized double-blind placebo-controlled study with customized injection approach. Parkinsonism & Related Disorders 2018, 56: 65-69. PMID: 29929813, DOI: 10.1016/j.parkreldis.2018.06.019.Peer-Reviewed Original ResearchConceptsHand weaknessEssential hand tremorDouble-blind placebo-controlled studyEssential tremorAdministration of onabotulinumtoxinASevere hand weaknessPlacebo-controlled studyClinical rating scoresHand tremorRating scoresParkinson's disease tremorIncobotulinumtoxinA injectionsCrossover trialPatients' perceptionsBotulinum toxinTreatment efficacyClinical practiceHand strengthForearm musclesTremor severityClinical scalesTremorWeeksTreatmentInjection
2017
RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials
Dashtipour K, Bhidayasiri R, Chen JJ, Jabbari B, Lew M, Torres-Russotto D. RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials. Journal Of Clinical Movement Disorders 2017, 4: 9. PMID: 28593050, PMCID: PMC5460542, DOI: 10.1186/s40734-017-0055-1.Peer-Reviewed Original ResearchAdverse eventsClinical trialsSystematic reviewDose-dependent adverse eventsMethodsA systematic literature reviewMild transient dysphagiaMost adverse eventsComparative clinical studyTreatment of patientsMedical literature databasesDry mouthTransient dysphagiaMild weaknessClinical studiesToxin effectsLiterature databasesBoNTIndividual studiesTrialsTreatmentPrimary publicationsDosesSystematic literature reviewSignificant benefitsReview
2016
Effective Treatment of Paroxysmal Nonkinesigenic Dyskinesia With Oxcarbazepine
Kumar A, Szekely A, Jabbari B. Effective Treatment of Paroxysmal Nonkinesigenic Dyskinesia With Oxcarbazepine. Clinical Neuropharmacology 2016, 39: 201-205. PMID: 27046658, DOI: 10.1097/wnf.0000000000000149.Peer-Reviewed Original ResearchConceptsParoxysmal nonkinesigenic dyskinesiaRare chronic disorderOutcome of treatmentSeverity of episodesAvailable therapiesChronic disordersClinical trialsInvoluntary movementsEffective treatmentOxcarbazepinePharmaceutical agentsDyskinesiaPatientsTreatmentDisordersTherapyDebilitatingDiseaseTrialsSeverityBotulinum Toxin Treatment of Spasticity in Adults and Children
Moeini-Naghani I, Hashemi-Zonouz T, Jabbari B. Botulinum Toxin Treatment of Spasticity in Adults and Children. Seminars In Neurology 2016, 36: 064-072. PMID: 26866498, DOI: 10.1055/s-0036-1571847.Peer-Reviewed Original ResearchConceptsCerebral palsyPlacebo-controlled clinical trialDoses of BoNTSpasticity of childrenBotulinum toxin treatmentAdult spasticityTherapeutics subcommitteeBoNT treatmentPharmacologic treatmentFrequent symptomsMultiple sclerosisSpinal traumaClinical trialsToxin treatmentSpasticityAmerican AcademyPalsyBotulinum neurotoxinTreatmentChildrenWorld literatureEfficacyAdultsSclerosisPathophysiology
2015
Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins
Schaefer SM, Gottschalk CH, Jabbari B. Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins. Toxins 2015, 7: 2615-2628. PMID: 26184313, PMCID: PMC4516932, DOI: 10.3390/toxins7072615.Peer-Reviewed Original ResearchConceptsChronic migraineBotulinum toxin injection therapyLarge healthcare costsBotulinum toxin therapyTreatment of migraineCommon neurological disorderToxin therapyInjection therapyPathophysiological mechanismsMigraine pathophysiologyHealthcare costsMigraineNeurological disordersAnimal dataBotulinum neurotoxinTherapyTreatmentInjection techniqueCurrent understandingMedicationsPathophysiologyTremor and Klinefelter’s Syndrome
Rabin ML, Mittal SO, Jabbari B. Tremor and Klinefelter’s Syndrome. Tremor And Other Hyperkinetic Movements 2015, 5: 304. PMID: 26175955, PMCID: PMC4473154, DOI: 10.7916/d84m93kr.Peer-Reviewed Original Research
2012
Orofacial Dyskinesia After Moxifloxacin Treatment—A Case With Normal Hepatorenal Function and Review of Literature
Mittal SO, Machado DG, Jabbari B. Orofacial Dyskinesia After Moxifloxacin Treatment—A Case With Normal Hepatorenal Function and Review of Literature. Clinical Neuropharmacology 2012, 35: 292-294. PMID: 23151468, DOI: 10.1097/wnf.0b013e31826ba0eb.Peer-Reviewed Original ResearchConceptsOrofacial dyskinesiaReview of literatureThird-generation fluoroquinoloneFourth-generation fluoroquinolone moxifloxacinFourth-generation fluoroquinolonesAcute bronchitisKidney functionFirst patientHepatorenal functionLiver functionMovement disordersInvoluntary movementsDyskinesiaFluoroquinolone moxifloxacinPatientsMoxifloxacinFacial musclesFluoroquinolonesAntibioticsSignificant reductionTreatmentFluoroquinolone antibioticsClonidineDiscontinuationBronchitisOnabotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation
Mittal S, Machado DG, Jabbari B. OnabotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation. Pain Medicine 2012, 13: 1029-1033. PMID: 22776097, DOI: 10.1111/j.1526-4637.2012.01437.x.Peer-Reviewed Original ResearchConceptsQuality of lifeCancer patientsCancer painLocal treatmentEffect of onabotulinumtoxinAPatient global assessmentAreas of surgeryFocal painMasseter injectionLocal surgeryPain reliefPain areaRepeat injectionsRepeat treatmentPainPatientsSecond injectionSignificant improvementOnabotulinumtoxinAGlobal assessmentSurgeryJaw musclesTreatmentInjectionRelief
2010
Botulinum Toxin A for Treatment of Allodynia of Complex Regional Pain Syndrome: A Pilot Study
Safarpour D, Salardini A, Richardson D, Jabbari B. Botulinum Toxin A for Treatment of Allodynia of Complex Regional Pain Syndrome: A Pilot Study. Pain Medicine 2010, 11: 1411-1414. PMID: 20609130, DOI: 10.1111/j.1526-4637.2010.00897.x.Peer-Reviewed Original ResearchConceptsComplex regional pain syndromeRegional pain syndromeBotulinum toxin APain syndromeToxin AOpen-label protocolPain Impact QuestionnairePlacebo-controlled protocolTreatment of allodyniaBrief Pain InventoryMcGill Pain QuestionnaireGlobal satisfaction scaleAllodynic areaAllodynic skinPain InventoryPain QuestionnaireImpact QuestionnaireSubcutaneous administrationPatientsSatisfaction ScaleAllodyniaPilot studySyndromeBoNTTreatment
2008
Botulinum neurotoxins in the treatment of refractory pain
Jabbari B. Botulinum neurotoxins in the treatment of refractory pain. Nature Reviews Neurology 2008, 4: 676-685. PMID: 19043424, DOI: 10.1038/ncpneuro0948.Peer-Reviewed Original Research